ArticlePloS one2020
Structure-based drug repositioning explains ibrutinib as VEGFR2 inhibitor.
Melissa F Adasme et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ArticlePloS one2020
Melissa F Adasme et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.